safinamide has been researched along with methamphetamine in 1 studies
| Studies (safinamide) | Trials (safinamide) | Recent Studies (post-2010) (safinamide) | Studies (methamphetamine) | Trials (methamphetamine) | Recent Studies (post-2010) (methamphetamine) |
|---|---|---|---|---|---|
| 199 | 29 | 159 | 10,914 | 409 | 4,888 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heidarian, S; Motaghinejad, M; Safari, S; Sepehr, A; Taheri, F | 1 |
1 other study(ies) available for safinamide and methamphetamine
| Article | Year |
|---|---|
Neuroprotective and neuro-survival properties of safinamide against methamphetamine-induced neurodegeneration: Hypothetic possible role of BDNF/TrkB/PGC-1α signaling pathway and mitochondrial uncoupling protein -2(UCP-2).
Topics: Alanine; Benzylamines; Brain-Derived Neurotrophic Factor; Humans; Methamphetamine; Neuroprotection; Receptor, trkB; Signal Transduction; Uncoupling Protein 1; Uncoupling Protein 2 | 2020 |